Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Major depressive disorder is typically treated with selective serotonin reuptake inhibitors (SSRIs), however, SSRIs take approximately six weeks to produce therapeutic effects, if any. Not surprisingly, there has been great interest in findings that low doses of ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, produce rapid and long-lasting antidepressant effects. Preclinical studies show that the antidepressant-like effects of ketamine are dependent upon availability of serotonin, and that ketamine increases extracellular serotonin, yet the mechanism by which this occurs is unknown. Here we examined the role of the high-affinity, low-capacity serotonin transporter (SERT), and the plasma membrane monoamine transporter (PMAT), a low-affinity, high-capacity transporter for serotonin, as mechanisms contributing to ketamine’s ability to increase extracellular serotonin and produce antidepressant-like effects. Using high-speed chronoamperometry to measure real-time clearance of serotonin from CA3 region of hippocampus in vivo, we found ketamine robustly inhibited serotonin clearance in wild-type mice, an effect that was lost in mice constitutively lacking SERT or PMAT. As expected, in wild-type mice, ketamine produced antidepressant-like effects in the forced swim test. Mapping onto our neurochemical findings, the antidepressant-like effects of ketamine were lost in mice lacking SERT or PMAT. Future research is needed to understand how constitutive loss of either SERT or PMAT, and compensation that occurs in other systems, is sufficient to void ketamine of its ability to inhibit serotonin clearance and produce antidepressant-like effects. Taken together with existing literature, a critical role for serotonin, and its inhibition of uptake via SERT and PMAT, cannot be ruled out as important contributing factors to ketamine’s antidepressant mechanism of action. Combined with what is already known about ketamine’s action at NMDA receptors, these studies help lead the way to the development of drugs that lack ketamine’s abuse potential but have superior efficacy in treating depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the antidepressant-like effects of ketamine (32 mg/kg i.p.) were absent in mice lacking SERT or plasma membrane monoamine transporter (PMAT) (Bowman et al., 2020).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Bowman et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“These behavioral effects corresponded to a reduction in serotonin clearance in the CA3 region of the hippocampus in WT mice but not SERT or PMAT knockout mice.”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Bowman et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · cited 1×
“Currently this is viewed as the primary mechanism underlying ketamine’s antidepressant-like effects in preclinical studies [8,10].”
BackgroundNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 1×
“Ketamine triggers intracellular signaling pathways, including eukaryotic elongation factor 2 (eEF2) kinase, resulting in rapid increases in brain derived neurotrophic factor (BDNF) protein translation [8,9].”
BackgroundNMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609 · cited 5×
“To gain a better understanding of the relationship between plasma and brain concentrations of ketamine and antidepressant-like effect in rodents, Can and colleagues [20] measured plasma and brain tissue concentrations of ketamine and its metabolites after systemic administration of 10 mg/kg ketamine in mice, a sub-ane…”
BackgroundMethodResultInfluentialKetamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260 · cited 2×
“Ketamine at anesthetic doses is reported to increase serotonin, which may be involved in the psychotic-like symptoms occurring during ketamine emergence [58].”
BackgroundThe ascent of mouse: advances in modelling human depression and anxiety
Cryan, J. F., & Holmes, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1825 · Cited by 1,198
The spectrum of behaviors influenced by serotonin
Lucki, I. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00139-5 · Cited by 1,158 · cited 1×
“The antidepressant effect of SSRIs is initiated by blockade of the serotonin transporter (SERT) and ensuing increase in extracellular serotonin [11,12].”
BackgroundCryan, J. F., Valentino, R. J., & Lucki, I. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.008 · Cited by 1,119 · cited 1×
“We also looked for climbing behavior, which is routinely recorded during the FST when using rats as it aids in determining if the antidepressant-like actions of a drug are more strongly influenced by serotonergic or noradrenergic and dopaminergic systems; drugs that act to increase serotonin increase swimming, whereas…”
BackgroundThe role of the hippocampus in the pathophysiology of major depression
Campbell, S., & MacQueen, G. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0441 · Cited by 880 · cited 6×
“Like SSRIs, ketamine also causes robust increases in extracellular serotonin in brain regions important in the pathophysiology of mood disorders [13–15].”
BackgroundMethodInfluentialZarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811
Lucki, I. (1997) · Behavioural Pharmacology · doi:10.1097/00008877-199711000-00010 · Cited by 802 · cited 1×
“Forced swim test (FST) experiments were performed as described by Lucki [78].”
MethodCastagné, V., Moser, P., Roux, S., & Porsolt, R. D. (2011) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0810as55 · Cited by 702
Lucki, I., Dalvi, A., & Mayorga, A. (2001) · Psychopharmacology · doi:10.1007/s002130100694 · Cited by 506 · cited 1×
“Behaviors during the last four minutes of the swim session were scored [79].”
BackgroundCastagné, V., Moser, P., Roux, S., & Porsolt, R. D. (2010) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0508s49 · Cited by 466
Factors influencing behavior in the forced swim test
Bogdanova, O. V., Kanekar, S., D'Anci, K. E., & Renshaw, P. F. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.05.012 · Cited by 464 · cited 1×
“We also looked for climbing behavior, which is routinely recorded during the FST when using rats as it aids in determining if the antidepressant-like actions of a drug are more strongly influenced by serotonergic or noradrenergic and dopaminergic systems; drugs that act to increase serotonin increase swimming, whereas…”
BackgroundTreatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
McIntyre, R. S., Filteau, M.-J., Martin, L., Patry, S., Carvalho, A., Cha, D. S., Barakat, M., & Miguelez, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.043 · Cited by 421 · cited 1×
“as selective serotonin reuptake inhibitors (SSRIs) [3], underscoring a dire need for novel medications that are effective in treating all individuals suffering from depression.”
BackgroundKoike, H., Iijima, M., & Chaki, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.035 · Cited by 346 · cited 13×
“Although there are some reports of ketamine producing antidepressant-like effects in mice in the TST [62,64], our data support those of others who find the TST insensitive to detecting antidepressant-like effects of ketamine [42].”
MethodInfluentialDesigning Experiments and Analyzing Data
Maxwell, S. E., Delaney, H. D., & Kelley, K. (2017) · Routledge eBooks · doi:10.4324/9781003476252 · Cited by 317
KETAMINE INFUSIONS: PHARMACOKINETICS AND CLINICAL EFFECTS
IDVALL, J., AHLGREN, I., ARONSEN, K. F., & STENBERG, P. (1979) · British Journal of Anaesthesia · doi:10.1093/bja/51.12.1167 · Cited by 306 · cited 1×
“For example, in humans, plasma concentrations of ketamine needed for anesthesia are reported to be ~9 μM [55], while subanesthetic doses of ketamine used for treatment of depression result in plasma concentrations less than 1 μM [56–58].”
BackgroundLoo, C. K., Gálvez, V., O'Keefe, E., Mitchell, P. B., Hadzi‐Pavlovic, D., Leyden, J., Harper, S., Somogyi, A. A., Lai, R., Weickert, C. S., et al. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12572 · Cited by 257
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
Fukumoto, K., Toki, H., Iijima, M., Hashihayata, T., Yamaguchi, J.-I., Hashimoto, K., & Chaki, S. (2017) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239228 · Cited by 252 · cited 15×
“Although there are some reports of ketamine producing antidepressant-like effects in mice in the TST [62,64], our data support those of others who find the TST insensitive to detecting antidepressant-like effects of ketamine [42].”
ResultInfluentialSex differences in the antidepressant-like effects of ketamine
Carrier, N., & Kabbaj, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.009 · Cited by 251
Ketamine for Treatment-Resistant Unipolar Depression: Current Evidence
Mathew, S. J., Shah, A., Lapidus, K., Clark, C., Jarun, N., Ostermeyer, B., & Murrough, J. W. (2012) · CNS Drugs · doi:10.2165/11599770-000000000-00000 · Cited by 238
Multiple Comparisons: Theory and Methods
Hsu, J. (1996) · Chapman & Hall/CRC eBooks · doi:10.1201/b15074 · Cited by 228
Daws, L. C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.004 · Cited by 223 · cited 1×
“These findings pave the way for future experiments to interrogate the role, and mechanism of action, of SERT and PMAT in the antidepressant actions of ketamine, which will add to literature suggesting that concurrent blockade of SERT and “uptake-2” transporters, such as PMAT, has greater antidepressant efficacy than S…”
BackgroundSelf-citationMathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220
Franceschelli, A., Sens, J., Herchick, S., Thelen, C., & Pitychoutis, P. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.008 · Cited by 198
Targeting Homeostatic Synaptic Plasticity for Treatment of Mood Disorders
Kavalali, E. T., & Monteggia, L. M. (2020) · Neuron · doi:10.1016/j.neuron.2020.05.015 · Cited by 179 · cited 3×
“Not surprisingly, most preclinical studies have therefore focused on how blockade of NMDA receptors can exert antidepressant-like effects [8].”
BackgroundLindefors, N., Barati, S., & O'Connor, W. T. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00255-2 · Cited by 178
Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
Gigliucci, V., O’Dowd, G., Casey, S., Egan, D., Gibney, S., & Harkin, A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3024-x · Cited by 177
Fukumoto, K., Iijima, M., & Chaki, S. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.233 · Cited by 174 · cited 4×
“However, first we used wild-type (C57BL/6) mice to confirm, in our hands, that 32 mg/kg ketamine produced robust (near maximal) antidepressant-like effects, as reported by others [16,40,41].”
MethodResultInfluentialBaganz, N. L., Horton, R. E., Calderon, A. S., Owens, W. A., Munn, J. L., Watts, L. T., Koldzic-Zivanovic, N., Jeske, N. A., Koek, W., Toney, G. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800466105 · Cited by 172 · cited 7×
“Replicating our findings in wild-type C57BL/6 mice, ketamine produced a robust antidepressant-like effect in SERT+/+ mice, which was absent in SERT−/−mice.”
BackgroundMethodResultInfluentialSelf-citationOpioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents
Klein, M. E., Chandra, J., Sheriff, S., & Malinow, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916570117 · Cited by 156 · cited 1×
“Clearly, the mechanisms contributing to ketamine’s effects are complex, given its well-known action at NMDA receptors, its myriad effects on monoamine neurotransmission, and the recently reported dependency of ketamine on the opioid system for its antidepressant properties [65].”
BackgroundAntidepressant actions of ketamine: from molecular mechanisms to clinical practice
Monteggia, L. M., & Zarate, C. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.12.004 · Cited by 149
Pham, T. H., Mendez-David, I., Defaix, C., Guiard, B. P., Tritschler, L., David, D. J., & Gardier, A. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.010 · Cited by 136
Hypoinsulinemia Regulates Amphetamine-Induced Reverse Transport of Dopamine
Williams, J. M., Owens, W. A., Turner, G. H., Saunders, C., Dipace, C., Blakely, R. D., France, C. P., Gore, J. C., Daws, L. C., Avison, M. J., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050274 · Cited by 135
Self-citationImre, G., Fokkema, D. S., den Boer, J. A., & Horst, G. J. T. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.01.010 · Cited by 134
Pham, T. H., Defaix, C., Xu, X., Deng, S.-X., Fabresse, N., Alvarez, J.-C., Landry, D. W., Brachman, R. A., Denny, C. A., & Gardier, A. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.020 · Cited by 131 · cited 2×
“Of course, because ketamine was delivered systemically in these behavioral studies, a role for metabolites of ketamine cannot be ruled out [20,41,46,49].”
BackgroundKetamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells
Nishimura, M., Sato, K., Okada, T., Yoshiya, I., Schloss, P., Shimada, S., & Tohyama, M. (1998) · Anesthesiology · doi:10.1097/00000542-199803000-00029 · Cited by 128 · cited 1×
“From that time to present day, investigators have used a variety of approaches to test this hypothesis, including measuring the ability of ketamine to inhibit uptake of tritiated ([3H])-serotonin into synaptosomes prepared from rodent brain [51], cell lines expressing murine or human SERT [52,53], and human platelets,…”
BackgroundRepeated Ketamine Exposure Induces an Enduring Resilient Phenotype in Adolescent and Adult Rats
Parise, E. M., Alcantara, L. F., Warren, B. L., Wright, K. N., Hadad, R., Sial, O. K., Kroeck, K. G., Iñiguez, S. D., & Bolaños-Guzmán, C. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.027 · Cited by 125
A role for presynaptic mechanisms in the actions of nomifensine and haloperidol
Garris, P. A., Budygin, E. A., Phillips, P. E. M., Venton, B. J., Robinson, D. L., Bergstrom, B. P., Rebec, G. V., & Wightman, R. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00005-8 · Cited by 117 · cited 1×
“This was the anesthetic of choice because it reportedly does not interfere with monoamine transporters [29,30].”
BackgroundCan, A., Zanos, P., Moaddel, R., Kang, H. J., Dossou, K. S. S., Wainer, I. W., Cheer, J. F., Frost, D. O., Huang, X.-P., & Gould, T. D. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.235838 · Cited by 115
Lindholm, J., Autio, H., Vesa, L., Antila, H., Lindemann, L., Hoener, M. C., Skolnick, P., Rantamäki, T., & Ċastrén, E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.015 · Cited by 112 · cited 2×
“However, this is in keeping with findings of others who have also found this dose to be ineffective in these tests [16,42,62,63].”
ResultVoltammetric Methods in Brain Systems
Boulton, A. A., Baker, G. B., & Adams, R. (1995) · Humana Press eBooks · doi:10.1385/0896033120 · Cited by 108
Fukumoto, K., Iijima, M., & Chaki, S. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3378-0 · Cited by 107 · cited 2×
“However, first we used wild-type (C57BL/6) mice to confirm, in our hands, that 32 mg/kg ketamine produced robust (near maximal) antidepressant-like effects, as reported by others [16,40,41].”
MethodResultExaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice
Montañez, S., Owens, W. A., Gould, G. G., Murphy, D. L., & Daws, L. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01836.x · Cited by 106 · cited 1×
“Consistent with our previous findings [21,36,37], serotonin clearance trended to be slower in SERT−/− mice than their wild-type counterparts (T20-T60: (t(13) = 2.”
ResultSelf-citation(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
Yamaguchi, J.-I., Toki, H., Qu, Y., Yang, C., Koike, H., Hashimoto, K., Mizuno-Yasuhira, A., & Chaki, S. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0084-y · Cited by 105 · cited 13×
“Although there are some reports of ketamine producing antidepressant-like effects in mice in the TST [62,64], our data support those of others who find the TST insensitive to detecting antidepressant-like effects of ketamine [42].”
ResultInfluentialAmargós-Bosch, M., López-Gil, X., Artigas, F., & Adell, A. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005900 · Cited by 104
Berridge, C. W., Mitton, E., Clark, W., & Roth, R. H. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990601)32:3<187::aid-syn5>3.0.co;2-9 · Cited by 101
Lack of persistent effects of ketamine in rodent models of depression
Popik, P., Kos, T., Sowa-Kućma, M., & Nowak, G. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1158-z · Cited by 97 · cited 4×
“Although there are some reports of ketamine producing antidepressant-like effects in mice in the TST [62,64], our data support those of others who find the TST insensitive to detecting antidepressant-like effects of ketamine [42].”
ResultInfluentialdu Jardin, K. G., Liebenberg, N., Müller, H. K., Elfving, B., Sánchez, C., & Wegener, G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4327-5 · Cited by 93
Ago, Y., Tanabe, W., Higuchi, M., Tsukada, S., Tanaka, T., Yamaguchi, T., Igarashi, H., Yokoyama, R., Seiriki, K., Kasai, A., et al. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz041 · Cited by 92 · cited 2×
“Of course, because ketamine was delivered systemically in these behavioral studies, a role for metabolites of ketamine cannot be ruled out [20,41,46,49].”
BackgroundHorton, R. E., Apple, D. M., Owens, W. A., Baganz, N. L., Cano, S., Mitchell, N. C., Vitela, M., Gould, G. G., Koek, W., & Daws, L. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5687-11.2013 · Cited by 88 · cited 3×
“These findings pave the way for future experiments to interrogate the role, and mechanism of action, of SERT and PMAT in the antidepressant actions of ketamine, which will add to literature suggesting that concurrent blockade of SERT and “uptake-2” transporters, such as PMAT, has greater antidepressant efficacy than S…”
BackgroundMethodSelf-citationEthanol Inhibits Clearance of Brain Serotonin by a Serotonin Transporter-Independent Mechanism
Daws, L. C., Montanez, S., Munn, J. L., Owens, W. A., Baganz, N. L., Boyce-Rustay, J. M., Millstein, R. A., Wiedholz, L. M., Murphy, D. L., & Holmes, A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4050-05.2006 · Cited by 84 · cited 1×
“Consistent with our previous findings [21,36,37], serotonin clearance trended to be slower in SERT−/− mice than their wild-type counterparts (T20-T60: (t(13) = 2.”
ResultSelf-citationRepeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice
Thelen, C., Sens, J. P., Mauch, J., Pandit, R., & Pitychoutis, P. M. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.041 · Cited by 80
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
López-Gil, X., Jiménez-Sánchez, L., Campa, L., Castro, E., Frago, C., & Adell, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00288 · Cited by 80
Mice Genetically Depleted of Brain Serotonin Do Not Display a Depression-like Behavioral Phenotype
Angoa‐Pérez, M., Kane, M. J., Briggs, D. I., Herrera‐Mundo, N., Sykes, C. E., Francescutti, D. M., & Kuhn, D. M. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500096g · Cited by 76 · cited 1×
“The antidepressant effect of SSRIs is initiated by blockade of the serotonin transporter (SERT) and ensuing increase in extracellular serotonin [11,12].”
BackgroundYamamoto, S., Ohba, H., Nishiyama, S., Harada, N., Kakiuchi, T., Tsukada, H., & Domino, E. F. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.176 · Cited by 76 · cited 1×
“5 mg/kg) was found to reduce binding of [11C]-3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)benzonitrile ([11C]DASB) to SERT [50].”
BackgroundBaganz, N., Horton, R., Martin, K., Holmes, A., & Daws, L. C. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2740-10.2010 · Cited by 76
Self-citationTrujillo, K. A., Zamora, J. J., & Warmoth, K. P. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.014 · Cited by 73
Duan, H., & Wang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.436972 · Cited by 71 · cited 2×
“To date, the only study investigating compensation in other transporters in PMAT−/−mice found no increase in mRNA expression of SERT, NET, DAT, OCT1, OCT2, and OCT3 in choroid plexus [60], however, protein levels were not measured and the possibility of functional upregulation of one or more of these transporters in P…”
BackgroundZhou, M., Engel, K., & Wang, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.09.008 · Cited by 70 · cited 1×
“Since PMAT is the most efficient transporter of serotonin among D22-sensitive “uptake-2” transporters, and is widely expressed in human brain, including limbic regions important in controlling mood [25], the possibility is raised that inhibition of PMAT-mediated serotonin uptake may also contribute to ketamine’s antid…”
BackgroundSabeti, J., Gerhardt, G. A., & Zahniser, N. R. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00301-x · Cited by 69 · cited 1×
“This was the anesthetic of choice because it reportedly does not interfere with monoamine transporters [29,30].”
BackgroundRodent ketamine depression-related research: Finding patterns in a literature of variability
Polis, A. J., Fitzgerald, P. J., Hale, P. J., & Watson, B. O. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112153 · Cited by 67 · cited 1×
“We turned to the FST, which has been shown to provide more consistent results when examining the antidepressant-like effects of ketamine [43].”
ResultKetamine inhibits serotonin uptake in vivo
Martin, L. L., Bouchal, R. L., & Smith, D. J. (1982) · Neuropharmacology · doi:10.1016/0028-3908(82)90149-6 · Cited by 61 · cited 1×
“In 1982, Martin and colleagues [54] leveraged p-chloroamphetamine (PCA), a substrate for SERT that leads to depletion of serotonin, to gain insight into ketamine’s actions in vivo.”
BackgroundPerez, X. A., & Andrews, A. M. (2004) · Analytical Chemistry · doi:10.1021/ac049103g · Cited by 53 · cited 2×
“Carbon fiber electrodes were fabricated based on methods from Gerhardt [71,72] and described in Daws and Toney, and Williams et al.”
MethodActivity of the Serotonergic System During Isoflurane Anesthesia
Mukaida, K., Shichino, T., Koyanagi, S., Himukashi, S., & Fukuda, K. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000255200.42574.22 · Cited by 53
Azzaro, A. J., & Smith, D. J. (1977) · Neuropharmacology · doi:10.1016/0028-3908(77)90072-7 · Cited by 45
Isoflurane Decreases Extracellular Serotonin in the Mouse Hippocampus
Whittington, R. A., & Virág, L. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000221488.48352.61 · Cited by 44
Effects of opioids on human serotonin transporters
Barann, M., Stamer, U. M., Lyutenska, M., Stüber, F., Bönisch, H., & Urban, B. W. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1056-3 · Cited by 43 · cited 1×
“From that time to present day, investigators have used a variety of approaches to test this hypothesis, including measuring the ability of ketamine to inhibit uptake of tritiated ([3H])-serotonin into synaptosomes prepared from rodent brain [51], cell lines expressing murine or human SERT [52,53], and human platelets,…”
BackgroundKinoshita, H., Nishitani, N., Nagai, Y., Andoh, C., Asaoka, N., Kawai, H., Shibui, N., Nagayasu, K., Shirakawa, H., Nakagawa, T., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy007 · Cited by 38
Spies, M., James, G. M., Berroterán-Infante, N., Ibeschitz, H., Kranz, G. S., Unterholzner, J., Godbersen, M., Gryglewski, G., Hienert, M., Jungwirth, J., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx085 · Cited by 34 · cited 1×
“More recently, Spies and colleagues [59] used PET imaging in humans to examine the effects of 0.”
BackgroundRapid Chronocoulometric Measurements of Norepinephrine Overflow and Clearance in CNS Tissues
Gerhardt, G. A. (2003) · Humana Press eBooks · doi:10.1385/0-89603-312-0:117 · Cited by 31 · cited 2×
“Carbon fiber electrodes were fabricated based on methods from Gerhardt [71,72] and described in Daws and Toney, and Williams et al.”
MethodTargeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression
Bowman, M. A., & Daws, L. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00156 · Cited by 30 · cited 1×
“In parallel, we determined how ketamine’s effects on serotonin clearance mapped onto behavior in the tail suspension test (TST) and forced swim test (FST), commonly used behavioral assays that detect drugs with antidepressant potential [27,28].”
BackgroundSelf-citationHigh-Speed Chronoamperometry to Study Kinetics and Mechanisms for Serotonin Clearance In Vivo
Toney, G., & Daws, L. (2006) · Frontiers in Neuroengineering Series · doi:10.1201/9781420005868.ch5 · Cited by 29 · cited 3×
“Louis, MO, USA) was applied to carbon fiber electrodes to prevent anions in extracellular fluid from coming in contact with the carbon fiber [69,70].”
MethodSelf-citationDopamine uptake dynamics are preserved under isoflurane anesthesia
Brodnik, Z. D., & España, R. A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.046 · Cited by 29
Iravani, M. M., Muscat, R., & Kruk, Z. L. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990601)32:3<212::aid-syn7>3.0.co;2-m · Cited by 27
Targeting Treatment-Resistant Depression
Mathys, M. L., & Mitchell, B. G. (2011) · Journal of Pharmacy Practice · doi:10.1177/0897190011426972 · Cited by 22 · cited 1×
“Suicide rates have increased dramatically in recent years [1], and treatment resistant depression is a leading cause of suicide [2].”
BackgroundGilman, T. L., George, C. M., Vitela, M., Herrera‐Rosales, M., Basiouny, M. S., Koek, W., & Daws, L. C. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13968 · Cited by 22 · cited 1×
“This idea is further supported by PMAT−/− mice displaying normal behavior in a battery of tests, with only subtle differences in anxiety-like and coping behaviors compared to PMAT+/+ mice reported [61].”
ResultSelf-citationThe influence of isoflurane on the synaptic activity of 5-hydroxytryptamine
Martin, D. C., Adams, R. J., & Aronstam, R. S. (1990) · Neurochemical Research · doi:10.1007/bf00965741 · Cited by 18
Isoflurane causes concentration-dependent inhibition of medullary raphé 5-HT neurons in situ
Johansen, S. L., Iceman, K. E., Iceman, C. R., Taylor, B. E., & Harris, M. B. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.07.002 · Cited by 16
Research works printed but not linked: 1
- Sitte, H., and Bonisch, H. (2016). High-speed chronoamperometry to measure biogenic amine release and uptake in vivo. Neurotransmitter Transporters–Investigate Methods, Humana Press.
Cited by
Mechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Yoshida, K., Drew, M. R., Kono, A., Mimura, M., Takata, N., & Tanaka, K. F. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00990-y · Cited by 55
“The suppressive effects of these drugs on vHP activity may be mediated by direct or indirect serotoninmediated inhibition [20, 46], ketamine-mediated NMDA receptor blockade [37, 40], or ketamine-mediated serotonin uptake inhibition [47]; however, more detailed investigations will be necessary to explain the temporal s…”
BackgroundIUPHAR review: Navigating the role of preclinical models in pain research
Karimi, S. A., Zahra, F. T., & Martin, L. J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107073 · Cited by 38
Electrochemical and biosensor techniques to monitor neurotransmitter changes with depression
Dunham, K. E., & Venton, B. J. (2024) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-024-05136-9 · Cited by 34
“In addition to glutamate, ketamine may also have effects on serotonin receptors and SERT, but the evidence is less clear [33, 87].”
BackgroundMethodResultInfluentialGu, Y., Zhang, N., Zhu, S., Lu, S., Jiang, H., & Zhou, H. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174939 · Cited by 31
Metadata
- Authors
- Bowman, M. A., Vitela, M., Clarke, K. M., Koek, W., & Daws, L. C.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Daws, Lynette C.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-10-14
- Volume
- 21
- Issue
- 20
- Pages
- 7581
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7589995
- OpenAlex
- W3092969389
- Cited by
- 33
- References
- 79
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 7 · 2021: 10 · 2020: 1
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (R01MH093320, R01MH106978)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- ketamine, antidepressant mechanism, serotonin transporter, plasma membrane monoamine transporter, serotonin clearance, extracellular serotonin, major depressive disorder, NMDA receptor antagonists, hippocampal CA3, forced swim test
- MeSH terms
- Animals, Antidepressive Agents, Ketamine, Male, Mice, Inbred C57BL, Nucleus Accumbens, Serotonin, Equilibrative Nucleoside Transport Proteins, Serotonin Plasma Membrane Transport Proteins, Mice, CA3 Region, Hippocampal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.